Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters

Journal of Child and Adolescent Psychopharmacology

Volumn 11, Issue 1, 2001, Pages 15-24

  Moll, G H ^a   Hause, S ^a   Ruther E ^a   Rothenberger, A ^a   Huether, G ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE TRANSPORTER; METHYLPHENIDATE; NISOXETINE; PAROXETINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN DEVELOPMENT; CONTROLLED STUDY; CORPUS STRIATUM; DENSITY; DRUG EFFECT; MALE; MESENCEPHALON; MONOAMINERGIC SYSTEM; NEWBORN; NONHUMAN; RAT;

EID: 0035073770     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454601750143366     Document Type: Article

References (41)

1. Prenatal cocaine exposure disrupts the development of the serotonergic system
2. 3H]GBR-12935 binding to human cerebral cortex is not to dopamine uptake sites
3. Pharmacologic studies on a new central stimulant, α-(2-piperidyl)benzhydrolhydrochloride (MRD-108)
4. Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the counting stroop
5. Implications of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder
6. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder
7. Frontal lobe disinhibition in attention deficit disorder
8. Stimulants in ADHD with Tourette's Syndrome
9. Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration
10. Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls
11. Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate
12. Regulation of nerve growth factor synthesis/secretion by catecholamine in cultured mouse astroglial cells
13. Catecholamines increase nerve growth factor mRNA content in both mouse astroglial cells and fibroblast cells
14. Locomotor hyperactivity and hypoexploration after lesion of the dopaminergic-A10 area in the ventral mesencephalic tegmentum (VMT) of rats
15. Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans
16. Dopaminergic transmitter up-regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) synthesis in mouse astrocytes in culture
17. Selective (+)-amphetamine neurotoxicity on striatal dopamine nerve terminals in the mouse
18. The striatum in a putative cerebral network activated by verbal awareness in normals and in ADHD children
19. Striatal dysfunction in attention deficit and hyperkinetic disorder
20. Magnetic resonance imaging measurement of the caudate nucleus in adolescents with attention-deficit hyperactivity disorder and its relationship with neurophysiological and behavioral measures
21. Ritalin, eine neuartige synthetische verbindung mit spezifischer zentralerregender wirkungskomponente
22. Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood
23. Dopaminergic stimulation up-regulates the in vivo expression of brain-derived neurotrophic factor (BDNF) in the striatum
24. La preprazione di piridil-e-piridilarilace-tonitr ilie di alcuni prodotti di transformazione (part 1a)
25. Different patterns of local brain energy metabolism associated with high and low doses of methylphenidate. Relevance to its action in hyperactive children
26. Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers
27. Altered reinforcement mechanisms in attention-deficit/hyperactivity disorder
28. 3H]Threo-(+/-)-methylphenidate binding to 3,4-dihydroxyphenylethylamine uptake sites in corpus striatum: Correlation with the stimulant properties of ritalinic acid esters
29. SPECT brain imaging abnormalities in attention deficit hyperactivity disorder
30. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration
31. Multiple ionic conductances of the human dopamine transporter: The actions of dopamine and psychostimulants
32. Attention deficit hyperactivity disorder: Advances in cognitive neurobiological, and genetic research
33. Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the fronto-cortical dopaminergic innervation in the rat
34. Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study
35. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate
36. Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate
37. Persistently increased density of serotonin transporters in the frontal cortex of rats treated with fluoxetine during early juvenile life
38. Methylphenidate and pemoline do not cause depletion of rat brain monoamine markers similar to that observed with metamphetamine
39. The stimulatory effect of brain-derived neurotrophic factor on dopaminergic phenotype expression of embryonic rat cortical neurons in vitro